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Abstract
Background: Recent findings suggest that individuals with Huntington’s dis-
ease (HD) have an impaired capacity to execute cognitive and motor tasks
simultaneously, or dual task, which gradually worsens as the disease advances.
The onset and neuropathological changes mediating impairments in dual task-
ing in individuals with HD are unclear. The reliability of dual tasking assess-
ments for individuals with HD is also unclear. Objectives: To evaluate
differences in dual tasking performance between individuals with HD
(presymptomatic and prodromal) and matched controls, to investigate associa-
tions between striatal volume and dual tasking performance, and to determine
the reliability of dual tasking assessments. Methods: Twenty individuals with
HD (10 presymptomatic and 10 prodromal) and 20 healthy controls were
recruited for the study. Individuals undertook four single and dual task assess-
ments, comprising motor (postural stability or force steadiness) and cognitive
(simple or complex mental arithmetic) components, with single and dual tasks
performed three times each. Participants also undertook a magnetic resonance
imaging assessment. Results: Compared to healthy controls, individuals with
presymptomatic and prodromal HD displayed significant deficits in dual task-
ing, particularly cognitive task performance when concurrently undertaking
motor tasks (P < 0.05). The observed deficits in dual tasking were associated
with reduced volume in caudate and putamen structures (P < 0.05),however,
not with clinical measures of disease burden. An analysis of the reliability of
dual tasking assessments revealed moderate to high test–retest reliability [ICC:
0.61-0.99] for individuals with presymptomatic and prodromal HD and healthy
controls. Conclusions: Individuals with presymptomatic and prodromal HD
have significant deficits in dual tasking that are associated with striatal degener-
ation. Findings also indicate that dual tasking assessments are reliable in indi-
viduals presymptomatic and prodromal HD and healthy controls.
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Introduction
The simultaneous execution of cognitive and motor tasks
(i.e., dual tasking) is essential for activities of daily living,
including driving and maintaining balance.1,2Recent evi-
dence suggests that individuals with Huntington’s disease
(HD) have greater difficulty executing dual tasks than
healthy controls, which adversely impacts on their func-
tional independence and quality of life.3,4
Existing studies have documented deficits in bimanual
tapping, walking while talking and speed accuracy trade-
off tasks in individuals with manifest HD.3,5-9 Such defi-
cits worsen with increasing task difficulty and are predic-
tive of cognitive and motor impairments in
HD.4,6,10While these findings provide compelling evidence
that dual tasking impairments are a prominent feature of
manifest HD, whether these deficits exist during the pre-
manifest stages and whether progressive striatal degenera-
tion underpins these deficits remains unclear.
The striatum, which shows early and strikingly selective
degeneration in HD,11-13 has been suggested to be funda-
mentally involved in dual tasking.14 Recent studies in indi-
viduals with Parkinson’s disease (PD) noted significant
associations between greater striatal damage and dual task-
ing deficits.15,16To our knowledge, associations between
striatal degeneration and dual tasking have not been inves-
tigated in individuals with HD. Considering the early loss
of functional segregation within the striatum,17,18it is likely
that striatal degeneration underlies, at least in part, dual
tasking deficits observed in individuals with HD. Studies
are nevertheless needed to test this supposition. There is
also a fundamental need to evaluate whether dual tasking
deficits arise during the premanifest stages of HD. During
this period of the disease, participants are characterized as
having presymptomatic HD(pre-HD; little to no clinical
signs) orprodromal HD (pro-HD; subtle, but unequivocal
signs to warrant formal diagnosis of the disease). Treat-
ment therapies are likely to have greatest therapeutic effect
during this period of the disease, when most neural struc-
tures are intact and remain remediable to therapeutic
strategies. It is, therefore, of vital importance to have sensi-
tive measures of disease onset and progression to enable
effective trailing of novel therapeutic strategies.
This study aimed to: (1) characterize differences in dual
tasking between individuals with pre-HD and pro-HD
and healthy age- and gender-matched controls, (2) inves-
tigate associations between striatal volume and dual task-
ing performance, and (3) determine the reliability of dual
task assessments in individuals with HD. Based on exist-
ing evidence, we hypothesized that individuals with HD
would exhibit significant deficits in dual tasking, com-
pared to healthy controls, and that such deficits would be
associated with greater striatal degeneration.
Methods and Materials
Ethical approval and patient consent
All research procedures were conducted in accordance
with the Declaration of Helsinki. Ethical approval for this
study was granted by Edith Cowan University (13145)
and North Metropolitan Area Mental Health Service
(2009-16) Human Research Ethics Committees. Research-
ers ensured that all participants understood the require-
ments of the study. Written and informed consent was
provided by all participants.
Participants
Twenty individuals with premanifest HD(10 pre-HD and
10 pro-HD) and 20 healthy age-and gender-matched con-
trols were recruited for this study. Inclusion criteria for
individuals with pre-HD and pro-HD were as follows: a
CAG repeat length >39, a diagnostic confidence level score
of ≤2 and a total functional capacity (TFC) score of 13 (
of a possible 13, indicating highest functional capacity) on
the Unified Huntington’s Disease Rating Scale [UHDRS-
TMS].19Individuals with a UHDRS-TMS score ≥ 5, a diag-
nostic confidence level (DCL) score of 2 and cognitive
impairments (as indicated by a composite score compris-
ing: Hopkins Verbal Learning Test, Symbol Digit Modali-
ties Test, Trail Making Test Part A and B, Cambridge One
Touch Stockings) were classified as pro-HD and individu-
als with a UHDRS-TMS score < 5, a DCL score between 0
and 2 and no validated clinical signs were classified as pre-
HD.20 Individuals with pre-HD and pro-HD were excluded
from the study if they had recent or ongoing substance
abuse or concomitant musculoskeletal, cardiovascular, or
sleep disorders. Inclusion and exclusion criteria for healthy
age- and gender-matched controls were as follows: no fam-
ily history of HD, no recent or ongoing substance abuse
and no known neurological, musculoskeletal, cardiovascu-
lar, or sleep disorders. Disease burden score (DBS) is a
measure of genetic burden and was calculated using the
method described by Penney et al. (1997).21 An index to
estimate proximity to diagnosis at study entry was
obtained using the CAP score (CAG-Age Product Scaled
score). CAP score was calculated by multiplying the age at
study entry by a scaling of the CAG repeat length as fol-
lows: CAPS = (Age × (CAG-33.66))/432.3326. CAP
scores <1, 1 and >1 indicate a 5-year diagnosis probability
of <0.5, 0.5, and >0.5, respectively.22
Experimental design
Similar to recent work in individuals with PD,15 participants
were asked to perform cognitive and motor tasks
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simultaneously to examine dual tasking ability. Each task was
performed for 20 seconds. To ensure the reliability of single
and dual task assessments: (a) the same examiners were used
to administer assessments, b) participants were familiarized
with single and dual task assessments prior to administration,
(c) assessments were administered in the same order for par-
ticipants (cognitive tasks prior to motor tasks and single tasks
prior to dual tasks [see Table 3 and 4 for testing order]), and
(d) test–retest data were collected to evaluate the reliability of
assessments for individuals with pre-HD, pro-HD and
healthy controls. Importantly, all assessments, including clin-
ical (UHDRS-TMS), dual tasking, and neuroimaging assess-
ments were performed within 4 weeks for all participants. All
examiners had significant experience working with people
with HD and therefore were not blinded to group status. Sin-
gle and dual task assessments were performed three times
each. Specific information on cognitive and motor tasks are
detailed below.
Cognitive tasks
Two numeracy assessments were used to evaluate cogni-
tive performance under single and dual task conditions.
Numeracy assessments included the Serial Threes Test
(STT) and a Progressive Subtraction Test (PST).23 The
STT requires participants to make multiple subtractions
of three from a whole three-digit number, e.g., 256, 253,
250, 247. The PST required participants to verbalize pro-
gressive subtractions of 1, 2, 3, 4, and 5 from a three-digit
whole number and the resulting minuends, e.g., 455, 453,
450, and 446. Different three-digit numbers were used for
each trial to reduce learning effects. Numeracy tests were
purposefully selected to evaluate cognitive performance
given their proven sensitivity in individuals with HD and
ecological validity (use in everyday life, particularly the
management of finances and time).24
Motor tasks
Postural stability and force steadiness tasks were used to
evaluate motor performance under single and dual task
conditions. The sensory organization test (SOT) on the
Neurocom Smart Balance Master was used to evaluate
postural stability. The SOT comprises six different sensory
conditions: 1) eyes open, fixed support, and surround-
ings, 2) eyes closed, fixed support, and surroundings, 3)
eyes open, fixed support, moving surroundings, 4) eyes
open, unstable support, fixed surroundings, 5) eyes
closed, unstable support, fixed surroundings, and 6) eyes
open, unstable support, and moving surroundings. For
the purpose of this study, only eyes open conditions (1,
3, 4, and 6) were used to ensure that outcomes were eco-
logically relevant. Values are expressed as a percentage of
the theoretical maximum angle of sway, therefore a score
of 100 indicates good stability and no movement of the
centre of gravity. The Biodex System 4 was used to evalu-
ate force steadiness in the right plantar flexors at 10% of
the maximum voluntary force that participants can gener-
ate. Prior to the commencement of force steadiness trials
participants performed three maximum voluntary isomet-
ric contractions (MVIC) of the right plantar flexors. The
highest force (Nm) generated in a single MVIC trial was
recognized as the participant’s maximum force output
and was used to calculate a 10% submaximal plantar flex-
ion contraction target force. With a television screen posi-
tioned in front of the participant, the participant was
asked to maintain the real-time force generation line on
the horizontal target force line (10% MVIC). The ampli-
tude of force fluctuations above and below the horizontal
target force line (force steadiness) during trials was quan-
tified and used for analysis. The higher the force fluctua-
tion the worse the performance. These tests were selected
based on their proven sensitivity in individuals with
HD.25-30For more detailed information see Supplementary
files.
Dual task performance
Dual task cost (DTC) values were calculated and analysed
to assess performance on dual tasks. The formula used to
calculate dual task cost values is provided below31
This formula enables calculation of DTC values (%
change) for cognitive and motor components of each dual
task. Negative values indicate a reduction in cognitive and
motor performance during dual tasking, compared to sin-
gle task performance, indicating an interference effect or
dual task cost.
MRI acquisition and analysis
T1-weighted structural images of the brain were obtained
from each participant using a GE Healthcare Discovery
MR750W 3T MRI scanner. Images were acquired with a
DTC %ð Þ¼ dual task performance single task performanceð Þ= single task performanceð Þð Þ100:
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24-channel head coil using a 3DIR-SPGR sequence (TA =
9 m 59 s, TR = 3 s, TE = 3.1 ms, TI = 400 ms, flip
angle = 11˚, field of view = 256 mm3, image matrix =
256 × 256 × 256, 1 mm3 isotropic voxels). The T1-
weighted MRI images were automatically processed with
the processing pipeline available in FreeSurfer.32 FreeSur-
fer was used to parcellate the T1-weighted MRI data into
cortical and subcortical brain regions according to the
Desikan–Killiany atlas. The analyses were performed on
MASSIVE HPC (www.massive.org.au) using the “recon-
all” function. The neuroanatomical labels were inspected
for accuracy in all HD and healthy control cases. Using
the FreeSurfer processing outputs (aseg.stats), we
extracted volume of the striatum (caudate and putamen),
which were used in statistical analyses.
Statistical analysis and estimated sample size
Sample size was calculated based on the results reported by
Vaportzis et al5,6 on dual task cost in individuals with
manifest HD and controls performing two level tasks. At
the time of this study, there were no previous studies
describing dual task cost in individuals with pre-HD or
pro-HD. The sample size calculation was therefore based
on three group effects and interactions. From the results of
these previous studies it suffices that the minimum detect-
able effect size (Eta-squared) is set at 0.07. For a mixed-
model analysis of variance (ANOVA), to examine the
effects of group, gender, task, and interactions and using
an alpha level of 0.05, a statistical power of 0.8, it was esti-
mated a sample size of at least 10 participants per group.
Reliability of the single and dual tasks for each group
are given by the intraclass correlation (ICC), estimated
with a two-way mixed model for absolute agreement.
These values were estimated using trials collected as part
of the single dual tasking testing session. For ICC, values
less than 0.5, between 0.5 and 0.75, between 0.75 and 0.9,
and greater than 0.90 are indicative of poor, moderate,
good, and excellent reliability respectively.33
Mixed-model analysis of variance (ANOVA) was used
to examine the effects of task (single vs. dual), group
(pre-HD, pro-HD vs. control), gender (male vs. female)
and the two-way task × group and task × gender interac-
tions on STT, PST, force steadiness, and postural stability,
whilst adjusting for participant’s age. Pairwise compar-
isons were conducted with Bonferroni post-hoc test, and
where appropriate, contrasts were used to compare the
premanifest and prodromal HD individuals collectively to
healthy controls.
Effect sizes for the ANOVAs are described by partial
Eta-squared with 0.01, 0.06, and 0.14 identified as small,
medium, and large effects respectively. Post-hoc effect
sizes are described by Cohen’s d with small, medium, and
large effect sizes (in absolute terms) defined by 0.2, 0.5,
and 0.8 respectively.34
General linear modeling (GLM) was used to assess the
associations between dual task performance with clinical
disease outcomes and striatal volume separately for pro-
HD, pre-HD, and the healthy controls. The GLMs for the
HD groups were adjusted for gender and CAP as covari-
ates, whilst gender and age were accounted for in healthy
control GLMs. Benjamini-Hochberg correction was
applied to all p-values in order to minimize false discov-
ery rate. Within group analysis for dual task performance
and dual task cost are presented in the Supplementary
Files. All analyses were carried out using IBM SPSS ver-
sion 25 (IBM SPSS, Chicago, IL). Results were considered
significant at P ≤ 0.05.
Results
Demographic characteristics
Participants completed all experimental procedures
required for the study. Clinical and demographic data are
presented in Table 1. No significant differences were
observed between groups (pro-HD, pre-HD and control)
for gender. However, a significant difference in age was
observed between groups (P = 0.038), whereby the pro-
HD subjects were significantly older than the pre-HD
(P = 0.035). A significant difference was also observed for
the cognitive composite score, with individuals with pro-
HD displaying significantly reduced performance com-
pared to healthy controls.
Test–retest reliability of single and dual task
tests
Single task and dual task test–retest data are presented in
Table 2. Single task and dual task STT, PST, and force
steadiness assessments demonstrated moderate to excel-
lent test–retest reliability, with intraclass correlation coef-
ficient (ICC) values ranging between 0.61and 0.99. Single
task and dual task postural stability outcomes demon-
strated slightly lower test–retest reliability, with ICC val-
ues ranging from 0.50 to 0.94.
Group differences in single and dual task-
performance
Tables 3 and 4 outline the significant variables/interac-
tions identified in mixed models for single and dual tasks
and dual task costs respectively. The post-hoc results are
as follows. There were no significant differences in single
and dual tasks performance and dual task costs between
pre-HD and pro-HD.
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Single task performance
Performance on SOT, force steadiness, PST and STT tasks
did not differ significantly between groups (P > 0.05).
Age was negatively associated with performance on PST
(P = 0.002) and postural stability tasks (P < 0.024).
Dual task performance
Overall, individuals with pre-HD and pro-HD, compared
with controls, made fewer correct subtractions on the
STT task when concurrently undertaking the force steadi-
ness task (pre-HD + pro-HD P = 0.001; large ES =
−1.219; pre-HD P = 0.003; d = −1.435 and pro-HD
P = 0.001; d = −1.556). Furthermore, pro-HD individu-
als performed better than the controls on the STT task
when concurrently undertaking condition 4 (P = 0.046,
d = 0.987) and condition 6 (P = 0.011, d = 1.209) of the
SOT task. Similarly, pre-HD and pro-HD individuals
made significantly fewer correct subtractions on the PST
task than healthy controls when concurrently undertaking
the force steadiness task (HD P = 0.008; d = −1.022, pre-
HD P = 0.041; d =−1.043 and pro-HD P = 0.008; d
=−1.254), and as well as condition 6 (HD P < 0.001;
d = −1.623, pre-HD P = 0.011; d = −1.250 and pro-HD
P = 0.002; d = −1.452) of the SOT task. Pre-HD and
pro-HD individuals performed significantly worse on the
force steadiness task when concurrently undertaking STT
or PST tasks than healthy controls (HD P = 0.009,
d = −0.886). Age was negatively associated (P = 0.024)
with postural stability during single task and when con-
currently undertaking STT and PST (dual task).
Dual task cost analyses
Compared with healthy controls, individuals with HD
(pre-HD and pro-HD) demonstrated a deteriorated per-
formance on the STT task when concurrently undertaking
the force steadiness task (HD P < 0.001, d = −2.457; pre-
HD p < 0.001, d = −2.746 and pro-HD P < 0.001,
d = −2.778). The pre-HD and pro-HD groups overall
also demonstrated poorer performance than healthy con-
trols on the PST when concurrently undertaking force
steadiness task (HD P = 0.001, d = −1.112). Compared
with healthy controls, individuals with pro-HD demon-
strated a deteriorated performance on the STT task when
concurrently undertaking condition 1 (P = 0.002,
d = −1.118), condition 3 (P = 0.011; d = −1.029), condi-
tion 4 (P = 0.017; d = −1.140), and condition 6
(P = 0.001; d = −1.498) of the SOT task, but no signifi-
cant differences were observed with pre-HD. The pre-HD
and pro-HD groups overall also demonstrated poorer
performance than healthy controls on the PST when con-
currently undertaking condition 6 of the SOT task (HD
P = 0.011, d = −0.0.861). Contrary with expectations,
pre-HD and pro-HD individuals overall exhibited better
performance on the PST than healthy controls when con-
currently undertaking condition 1 of the SOT task (HD
P = 0.004, d = 0.996). Individuals with pre-HD per-
formed more poorly in the force steadiness task when
Table 1. Clinical and demographic characteristics of study cohorts.
Variable
Pre-HD
(n = 10)
Pro-HD
(n = 10)
Control
(n = 20) P value
Gender; n (%) 0.270a
Male 5 (50%) 2 (20%) 5 (25%)
Female 5 (50%) 8 (80%) 15 (75%)
Age1 36.5 (8.6) 50.1 (14.1) 42.1 (11.3) 0.038b
CAG repeats2 43.0 (42.0, 44.0) 41.5 (40.0, 44.2) -
DBS1 297.5 (84.6) 313.4 (86.2) -
CAP score1 0.8 (0.2) 0.9 (0.2) -
UHDRS-TMS2 0.5 (0.0, 1.2) 10.0 (7.8, 21.2) -
DCL2 0.0 (0.0, 0.0) 1.0 (0.8, 2.0) -
TFC 13 (0) 13 (0) -
Cognitive composite score 0.007 (2.93) −1.44 (2.52) 1.27 (1.07) 0.004c
Pre-HD: premanifest individuals with HD, Pro-HD: prodromal individuals with HD, CAG: cytosine-adenine-guanosine, DBS: disease burden score,
CAP score: CAG-Age Product Scaled score, UHDRS-TMS: Unified Huntington´s Disease Rating Scale-Total Motor Score, DCL: diagnostic confidence
level, TFC: total functional capacity score of the UHDRS-TMS.
1Normally distributed data, mean (SD) are presented.
2Data are non-normal, median (Q1, Q3) are presented.
aChi-square test.
bIndependent t-test
cKruskal–Wallis test (control vs. pre-HD, P = 0.111; control vs. pro-HD P = 0.002; pre-HD vs. pro-HD, P = 0.081).
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concurrently undertaking either STT or PST than the
healthy controls (HD P = 0.048, d = −1.018). No inter-
ference effects were found for postural stability tasks
when undertaking cognitive tasks. However, age was neg-
atively associated with postural stability across all SOT
conditions (P = 0.040). Figure 1 provides a visual repre-
sentation of the patterns of dual task cost for individuals
with pre-HD, pro-HD, and healthy controls. The figure
shows that individuals with pre-HD and pro-HD demon-
strated reduced cognitive performance when performing
the SOT and the force steadiness tasks.
Given the small sample size and lack of significant dif-
ferences observed between pre-HD and pro-HD sub-
groups, associations among dual task performance,
clinical disease outcomes, and striatal volume, were
undertaken with both pre-HD and pro-HD groups amal-
gamated.
Associations between dual task performance and
clinical disease outcomes in individuals with HD
No consistent associations were found between dual task
outcomes and clinical disease outcomes. STT DTC values
when undertaking the force steadiness task were nega-
tively associated with DBS (coefficient:-0.11, 95% CI −0.17
to −0.04, P = 0.014) and CAP (coefficient:-46.19, 95% CI
−74.73 to −17.95, P = 0.014). A negative association was
also found between UHDRS-TMS and condition 6 of the
postural stability task when undertaking the STT task (co-
efficient:-2.26, 95% CI −3.75 to −0.78, P = 0.046).
Associations between dual task performance and
striatal volume
Significant associations were observed between caudate
and putamen volume and performance on the STT when
HD participants (pre-HD and pro-HD) were concurrently
undertaking the force steadiness tasks (left caudate; coeffi-
cient:4.92, 95% CI 1.76 to 8.07, P = 0.034; right caudate;
coefficient:6.69, 95% CI 3.64 to 9.74, P = 0.006; left puta-
men; coefficient:3.04, 95% CI 2.04 to 4.04, P = 0.001;
right putamen,coefficient:2.88, 95% CI 0.86 to 4.91,
P = 0.038). Similar associations were found for the PST
and force steadiness dual task and caudate and putamen
volume in individuals with HD (pre-HD and post-HD)
(left caudate; coefficient:3.21, 95% CI 1.59 to 4.82,
P = 0.007; right caudate; coefficient:3.64, 95% CI 1.81 to
5.47, P = 0.007; left putamen; coefficient:1.44, 95% CI
0.69 to 2.19, P = 0.007). There were no significant associ-
ations between caudate and putamen volume and perfor-
mance on force steadiness and postural stability tasks
when undertaking subtraction tasks (P > 0.05). There
were no associations between caudate and putamen vol-
ume and dual task outcomes in healthy controls
(P > 0.05).
Discussion
We investigated differences in dual tasking between indi-
viduals with pre-HD, pro-HD, and healthy controls, and
for the first time, associations between striatal volume
and dual tasking performance. In addition, we also inves-
tigated the reliability of dual tasking assessments in indi-
viduals with pre-HD, pro-HD, and healthy controls. Our
study revealed three main findings. First, individuals with
pre-HD and pro-HD, when compared to healthy controls,
display significant deficits in dual tasking, particularly
cognitive task performance when concurrently undertak-
ing motor tasks. Second, task-specific deficits in dual
tasking are associated with striatal degeneration, but not
Table 2. Reliability of single-task and dual-task outcomes (intraclass
correlation coefficients).
Single Task Dual Task Pre-HD Pro-HD Control
Serial threes test 0.99 0.99 0.98
Force Steadiness 0.99 0.99 0.99
Postural stability
Condition 1 0.92 0.80 0.96
Condition 3 0.94 0.95 0.96
Condition 4 0.96 0.93 0.97
Condition 6 0.90 0.93 0.96
Progressive
subtraction test
0.92 0.92 0.95
Force Steadiness 0.98 0.98 0.98
Postural stability
Condition 1 0.82 0.88 0.83
Condition 3 0.87 0.92 0.61
Condition 4 0.97 0.93 0.88
Condition 6 0.97 0.86 0.78
Force Steadiness 0.95 0.94 0.84
Serial threes test 0.91 0.72 0.84
Progressive
subtraction test
0.97 0.65 0.89
Postural stability
Condition 1 0.56 0.73 0.85
Condition 3 0.73 0.65 0.59
Condition 4 0.79 0.83 0.93
Condition 6 0.71 0.94 0.73
Serial threes test
Condition 1 0.50 0.72 0.83
Condition 3 0.90 0.90 0.91
Condition 4 0.91 0.84 0.84
Condition 6 0.87 0.94 0.86
Progressive
subtraction test
Condition 1 0.88 0.82 0.83
Condition 3 0.84 0.88 0.82
Condition 4 0.94 0.90 0.94
Condition 6 0.74 0.93 0.87
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clinical measures of disease burden. Third, the assessed
dual tasking assessments show acceptable test–retest relia-
bility in individuals with pre-HD, pro-HD, and healthy
controls.
Dual tasking performance
Consistent with previous studies in manifest HD,4-
7,9,10,35,36 we found significant task-specific deficits in dual
tasking in individuals with pre-HD and pro-HD.
Performance appeared to be moderated by age, with older
individuals and females displaying greater deficits in dual
tasking. Compared to healthy controls, individuals with
pre-HD and pro-HD exhibited a significant deterioration
in cognitive performance (fewer correct subtractions)
when concurrently undertaking motor tasks (force steadi-
ness or postural stability tasks). Interestingly, interference
effects appeared to be greater for the simple arithmetic
task (STT), when concurrently undertaking force steadi-
ness and postural stability tasks. This finding was
Table 3. Single and dual task performance for pre-HD, pro-HD, and healthy controls using mixed-model ANOVAs. Models were adjusted for gen-
der and age. Adjusted means (95% confidence intervals) are presented for each group. Only the notable interactions/variables (P < 0.05) are
shown in the table.
Single Task Dual Task Pre-HD Pro-HD Control
Notable
Interaction/
Variable P value
Partial
Eta-Squared
Serial threes test 11.6 (8.9, 14.3) 10.2 (7.4, 12.9) 10.9 (9.0, 12.8) task × group <0.001 0.429
Force steadinessa,b 9.1 (5.9, 12.3) 8.5 (5.2, 11.7) 15.8 (13.6, 18.0)
Postural stability
Condition 1 9.8 (7.3, 12.2) 7.9 (5.4, 10.4) 11.0 (9.3, 12.7)
Condition 3b 10.3 (8.1, 12.6) 8.1 (5.8, 10.4) 11.4 (9.8, 13.0)
Condition 4 10.6 (8, 13.2) 8.2 (5.6, 10.9) 11.5 (9.7, 13.4)
Condition 6b 11.4 (8.8, 13.9) 7.7 (5.2, 10.3) 12.3 (10.5, 14.0)
Progressive
subtraction test
6.6 (5.4, 7.8) 6.1 (4.9, 7.4) 7.5 (6.6, 8.3) task × group <0.001 0.221
Force steadinessa,b 5.6 (4.0, 7.2) 5.1 (3.5, 6.7) 8.1 (7.0, 9.2)
Postural stability
Condition 1 7.2 (6.1, 8.3) 6.5 (5.3, 7.6) 6.5 (5.7, 7.3)
Condition 3 6.8 (5.8, 7.8) 6.3 (5.3, 7.3) 7.7 (7.0, 8.4)
Condition 4 6.2 (4.9, 7.4) 5.6 (4.2, 6.9) 6.8 (5.9, 7.7)
Condition 6a,b 6.1 (4.9, 7.2) 5.7 (4.6, 6.8) 8.1 (7.3, 8.9)
Force steadinessc 3.0 (1.7, 4.4) 3.3 (1.8, 4.8) 2.1 (1.1, 3.1) group 0.031 0.180
Serial threes testc 5.4 (3.0, 7.8) 4.9 (2.4, 7.5) 2.3 (0.5, 4.0)
Progressive
subtraction testc
4.1 (2.4, 5.9) 5.2 (3.3, 7.1) 2.3 (1.1, 3.6)
Postural stability stability × age 0.024 0.252
Condition 1 93.8 (92.5, 95.1) 92.8 (91.4, 94.1) 95.1 (94.2, 96.0)
Condition 3 63.2 (55.3, 71.1) 66.1 (58.0, 74.2) 70.3 (64.8, 75.8)
Condition 4 80.5 (73.0, 88.1) 80.3 (72.5, 88.0) 76.4 (71.1, 81.6)
Condition 6 83.3 (79.4, 87.3) 85.3 (81.3, 89.3) 86.6 (83.8, 89.3)
Serial threes test
Condition 1 90.4 (87.9, 92.9) 87.8 (85.2, 90.4) 93.3 (91.6, 95.1)
Condition 3 89.3 (85.9, 92.6) 87.8 (84.3, 91.2) 90.9 (88.6, 93.3)
Condition 4 60.4 (50.4, 70.3) 55.7 (45.5, 65.8) 65.3 (58.4, 72.3)
Condition 6 76.7 (69.9, 83.4) 77.8 (70.9, 84.7) 78.3 (73.6, 83.0)
Progressive
subtraction test
Condition 1 87.0 (81.0, 93.0) 88.8 (82.7, 95.0) 84.5 (80.3, 88.7)
Condition 3 86.5 (83.0, 90.0) 86.6 (83.0, 90.2) 89.6 (87.2, 92.0)
Condition 4 85.7 (80.8, 90.7) 89.5 (84.4, 94.5) 87.2 (83.7, 90.6)
Condition 6 61.3 (52.1, 70.5) 56.5 (47.1, 65.9) 65.3 (58.9, 71.7)
aSignificant difference between Pre-HD and Control (P < 0.05).
bSignificant difference between Pro-HD and Control (P < 0.05).
cSignificant difference between Pre-HD and Pro-HD (P < 0.05).
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unexpected. We expected greater interference effects for
the complex arithmetic task (PST).While speculative, it is
possible that the cognitive tasks used in the present study
engaged different cognitive abilities that are differentially
affected in HD.37 In particular, the STT under dual task-
ing conditions may be more reliant on information pro-
cessing abilities, whereas the PST may be more reliant on
problem solving and memory abilities, which are less
impacted in the premanifest stages of HD.37Future studies
are needed to evaluate the clinical factors influencing dual
tasking impairments in HD.
While not significant, our results also show that cogni-
tive tasks have a marked interference effect on motor
tasks under dual task conditions, which aligns with
previous studies that have documented an interference
effect of cognitive tasks on walking and balance under
dual task conditions.3,4According to the task prioritization
model proposed by Yogev-Seligmann et al. (2012),38indi-
viduals prioritize specific motor or cognitive tasks to
avoid hazardous situations while under dual task condi-
tions. Based on this model, it is conceivable that individ-
uals with HD prioritized postural stability tasks rather
than arithmetic tasks to avoid falling, however, this
requires further investigation.31Together, these findings
indicate mutual interference of cognitive and motor tasks
under dual task conditions, however, more pronounced
interference effects for cognitive rather than motor task
performance individuals with pre-HD and pro-HD.
Table 4. Dual task cost results for pre-HD, pro-HD, and healthy controls using mixed-model ANOVAs. Models were adjusted for gender and age.
Adjusted means (95% confidence intervals) are presented for each group. Only the notable interactions/variables (P < 0.05) are shown in the
table.
Dual Task
Costs (%) Pre-HD Pro-HD Control
Notable
Interaction/
Variable P-value
Partial
Eta-
Squared
Serial threes
test
Force steadinessa,b −19.5 (−36.2, −2.7) −20.8 (−37.9, −3.7) 48.5 (36.8, 60.2) task × group <0.001 0.417
Postural stability
Condition 1b −9.9 (−23.6, 3.8) −21.1 (−35.1, −7.1) 1.7 (−7.9, 11.3)
Condition 3b −4.3 (−18.5, 9.9) −18.7 (−33.2, −4.2) 6.8 (−3.1, 16.8)
Condition 4b −4.4 (−18.7, 9.9) −16.9 (−31.5, −2.3) 7.3 (−2.7, 17.3)
Condition 6b 3.1 (−11.2, 17.4) −18.5 (−33.1, −3.8) 13.5 (3.5, 23.5)
Progressive
subtraction
test
Force steadinessb,c −12.8 (−29.7, 4.2) −21.2 (−38.6, −3.9) 10 (−1.9, 21.9) task × group <0.001 0.257
Postural stability
Condition 1c 14.7 (−4.2, 33.6) 14.3 (−5.1, 33.6) −12.5 (−25.7, 0.7)
Condition 3 4.0 (−6.5, 14.5) 5.6 (−5.2, 16.3) 4.0 (−3.3, 11.3)
Condition 4 −8.9 (−21.2, 3.5) −10.5 (−23.1, 2.2) −8.1 (−16.7, 0.5)
Condition 6c −10.6 (−25.6, 4.5) −6.3 (−21.6, 9.1) 10.1 (−0.4, 20.6)
Force
steadiness
Serial threes testb −109.4 (−185.3, −33.6) −37.1 (−118.7, 44.6) −7.5 (−63.1, 48.0) group 0.042 0.165
Progressive
subtraction testb
−56.8 (−104.7, −8.9) −57.2 (−108.8, −5.6) −15.5 (−50.6, 19.6)
Postural
stability1
Serial threes test age 0.040 0.118
Condition 1 −4.8 (−8.5, −1.1) −5.4 (−9.2, −1.6) −4.4 (−7.0, −1.8)
Condition 3 −7.8 (−14.2, −1.4) −9.8 (−16.3, −3.2) −9.7 (−14.1, −5.2)
Condition 4 −8.6 (−13.5, −3.7) −3.6 (−8.6, 1.5) −8.4 (−11.8, −4.9)
Condition 6 −12.3 (−26.0, 1.4) −13.1 (−27.1, 0.9) −5.5 (−15.0, 4.1)
Progressive
subtraction test
Condition 1 −4.5 (−7.6, −1.3) −1.3 (−4.5, 1.9) −4.0 (−6.2, −1.8)
Condition 3 −4.3 (−23.1, 14.5) −23.7 (−42.9, −4.4) −4.5 (−17.6, 8.7)
Condition 4 −7.8 (−11.2, −4.5) −3.0 (−6.4, 0.5) −7.3 (−9.6, −4.9)
Condition 6 −2.1 (−17.9, 13.7) −21.6 (−37.8, −5.4) −5.4 (−16.5, 5.6)
1Outcome is inversely associated with age.
aSignificant difference between Pre-HD and Control (P < 0.05).
bSignificant difference between Pro-HD and Control (P < 0.05).
cSignificant difference between (Pre-HD + Pro-HD) and Control (P < 0.05) through contrast.
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Neuropathological associations with dual
tasking performance
We found that deficits in dual tasking were more pro-
nounced in individuals with greater degeneration in cau-
date and putamen structures in individuals with HD
(pre-HD and pro-HD). To our knowledge, this is the first
study to report associations between striatal degeneration
and dual tasking in individuals with HD (pre-HD and
pro-HD). This finding was not surprising given the early
degeneration of the striatum in HD and the role of the
striatum in the parallel processing of cognitive and motor
activities39 and prioritization of tasks under dual tasking
conditions.31Interestingly, our findings are in alignment
with those reported in individuals with PD, who also
exhibit striatal pathology. Nieuwhof et al (2017) docu-
mented significant associations between pathological alter-
ations in striatal activation and dual tasking deficits in
individuals with PD. While tentative, these results suggest
that striatal degeneration, at least in part, underpins defi-
cits in dual tasking in individuals with HD (pre-HD and
pro-HD) and perhaps individuals with striatal pathology
in general. These cross-sectional findings nevertheless
need to be confirmed in larger observational studies.
Associations of clinical measures of disease
burden and dual tasking performance
Contrary with our expectations, no consistent associations
were observed between measures of disease burden and
dual tasking performance in individuals with HD (pre-
HD and pro-HD). These results are not overly surprising
and are likely attributed to the insensitivity of disease
burden measures during the premanifest stages of the dis-
ease, particularly considering the observed associations
between striatal damage and dual tasking performance.
Figure 1. Patterns of dual task cost according to the Plummer and Eskes framework.31 Prem: premanifest HD, Prod: prodromal HD, CT: controls,
STT: serial threes test, PST: progressive subtraction test, FS: force steadiness, C1-C4: conditions 1 to 4 of the sensory organisation test.
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Study limitations
This study is not without limitations. First, this was a
cross-sectional study, which did not enable examination
of the sensitivity of these measures over time. Second, this
study included individuals with pre-HD and pro-HD,
findings are therefore not generalizable across the spec-
trum of the disease. Additional studies are needed to
determine whether the examined dual tasks are sensitive
over time and across the spectrum of the disease. Third,
this study only examined associations between striatal
damage and dual task performance and therefore do not
reflect a causal link between striatal pathology and dual
tasking deficits. Future interventional studies designed to
interfere with striatal activity, for example noninvasive
brain stimulation techniques or pharmacological thera-
pies, are needed to determine a causal link between stri-
atal damage and dual task deterioration. Finally, we only
assessed associations between caudate and putamen brain
structures and dual tasking performance, as these are the
principle brain structures affected by the disease and sen-
sitive to early disease changes. It is important to note that
other brain structures are also affected, including the
cerebellum and brain stem,40,41 which may also influence
dual tasking in HD.42,43 Additional studies should investi-
gate the role of other subcortical and cortical structures
and dual tasking.
Conclusions
Our findings show, for the first time, that dual tasking
impairments are present in individuals with pre-HD pro-
HD and are associated with striatal degeneration. Further-
more, our findings show that dual tasking measures are
reliable in individuals with pre-HD and pro-HD. These
findings are of clinical interest given the negative impact
of dual tasking impairments on activities of daily living.
Furthermore, these findings are of interest given the
urgent need for sensitive measures of disease burden for
upcoming disease modifying drug trials. Finally, these
findings are of clinical interest to rehabilitation specialists,
who could use the examined dual tasking paradigms to
identify individuals with dual tasking impairments that
may benefit from dual task training, which has demon-
strated efficacy in individuals with PD, who similarly dis-
play striatal damage and associated dual tasking deficits.
Larger longitudinal studies are nevertheless needed to
confirm these findings.
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Figure S1. Schematic representation of the Sensory Orga-
nization Test (SOT).The SOT comprises six different sen-
sory conditions: 1) eyes open, fixed support, and
surroundings (static posturography), 2) eyes closed, fixed
support, and surroundings, 3) eyes open, fixed support,
moving surroundings, 4) eyes open, unstable support, fixed
surroundings, 5) eyes closed, unstable support, fixed sur-
roundings, and 6) eyes open, unstable support and moving
surroundings. Individuals were required to undertake three
20-second trials for each sensory condition. For each trial,
participants were instructed to stand upright with their
arms crossed against their chest. Postural stability perfor-
mance on each trial was expressed as an equilibrium score,
which is calculated by computing the difference between
each participant´s sway of the centre of gravity (COG) and
a theoretical maximum anterior-posterior sway of 12.5°.
When a participant´s COG has minimal or no sway, the
difference with the theoretical maximum sway is 12.5°.
Values are expressed as a percentage of the theoretical
maximum angle of sway, therefore, a score of 100 indicates
good stability and no movement of the COG. When a par-
ticipant’s COG moves beyond the limit of stability or the
participant has a fall, they receive a score of zero.
Supplementary Material. Force Steadiness testing details
and sensory organization test calculation. Results of the
within group analysis for dual task performance and dual
task cost.
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